CIK 0001527728 · Non-accelerated filer<br>Smaller reporting company
Lunai Bioworks Inc.
Sign in to watch- Ticker
- LNAI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452259340
- Phone
- 45 39179840
- Business address
- CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CA, 90067
- Former names
- RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-28 | Sindlev Rene Director | Purchase | +36,200 | $6.61 | $239K | 6,484,544 |
| 2019-05-28 | Sindlev Rene Director | Purchase | +36,200 | $6.61 | $239K | 6,479,530 |
| 2019-05-24 | Sindlev Rene Director | Purchase | +5,014 | $6.25 | $31K | 6,448,344 |
| 2019-05-22 | Sindlev Rene Director | Purchase | +500 | $5.76 | $3K | 6,443,330 |
| 2019-05-21 | Sindlev Rene Director | Purchase | +20,000 | $5.75 | $115K | 6,442,830 |
| 2019-01-10 | Gronfeldt-Sorensen Henrik Director | Purchase | +50,000 | $2.00 | $100K | 50,000 |
| 2019-01-10 | Gronfeldt-Sorensen Henrik Director | Option exercise · Warrant to purchase common stock | −50,000 | $2.00 | $100K | 0 |
| 2018-12-31 | Weird Science LLC 10% owner | Other acquisition | +1,268,880 | 18,814,163 | ||
| 2018-12-31 | Dybul Mark Executive Vice Chair | Other acquisition | +3,732 | 55,336 | ||
| 2018-12-31 | Sandler Carl Forest Jr Director | Other acquisition | +1,268,880 | 18,814,163 | ||
| 2018-12-27 | Sindlev Rene Director | Purchase | +92,968 | $8.00 | $744K | 5,115,137 |
| 2018-12-27 | Sindlev Rene Director | Option exercise | +1,307,693 | $1.30 | $1.7M | 6,422,830 |
| 2018-12-27 | Sindlev Rene Director | Option exercise · Warrant to Purchase Common Stock | −1,307,693 | $1.30 | $1.7M | 3,092,307 |
| 2018-11-21 | Dybul Mark Director | Grant or award · Option to Purchase Common Stock | +300,000 | $6.50 | $1.9M | 312,834 |
| 2018-09-19 | Sindlev Rene Director | Grant or award · Option to Purchase Common Stock | +7,840 | $5.74 | $45K | 7,840 |
| 2018-09-19 | Dybul Mark Director | Grant or award · Option to Purchase Common Stock | +5,226 | $5.74 | $30K | 12,834 |
| 2018-09-19 | SAPIRSTEIN JAMES Director | Grant or award · Option to Purchase Common Stock | +5,226 | $5.74 | $30K | 12,770 |
| 2018-09-19 | D An Evelyn Director | Grant or award · Option to Purchase Common Stock | +5,226 | $5.74 | $30K | 12,770 |
| 2018-05-24 | Leire, Eric Jean Marie Chief Executive Officer | Purchase | +200 | $5.33 | $1K | 72,746 |
| 2018-05-24 | Leire, Eric Jean Marie Chief Executive Officer | Purchase | +500 | $5.25 | $3K | 73,246 |
Page 9 of 10 · 198 trades